Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?
Author InfoAkira Babazono (Institute of Health Science, Kyushu University, Kasuga City, Fukuoka, Japan, Graduate School of Medical Sciences, Health Care Administration and Management, Kyushu University, Fukuoka City, Fukuoka, Japan) Motonobu Miyazaki (Department of Hygiene and Preventive Medicine, School of Medicine, Fukuoka University, Fukuoka City, Fukuoka, Japan) Hiroshi Une (Department of Hygiene and Preventive Medicine, School of Medicine, Fukuoka University, Fukuoka City, Fukuoka, Japan) Eiji Yamamoto (Department of Information Science, Okayama University of Science, Okayama City, Okayama, Japan) Toshihide Tsuda (Social and Environmental Life Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama City, Okayama, Japan) Yoshio Mino (College of Social Welfare, Osaka Prefecture University, Osaka City, Osaka, Japan) Alan L. Hillman (Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Penn